课题基金 / 基金详情

Mechanisms of beta-cell failure in diabetes

Mechanisms of beta-cell failure in diabetes
糖尿病β细胞衰竭的机制
批准号:
nhmrc : 427616
负责人:
A/Pr David Laybutt
金额:
$35.81万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

A/Pr David Laybutt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The current epidemic of type 2 diabetes represents a major global health problem, with over 7% of the Australians suffering the disease. While there is a well-established relationship between obesity and insulin resistance, the majority of overweight individuals do not develop type 2 diabetes because their pancreatic beta-cells compensate with enhanced insulin secretion. It is the failure of beta-cell compensation that is fundamental to the development of diabetes. The beta-cell is a highly specialised cell with a unique metabolic profile and differentiation specifically geared towards making these cells able to sense fluctuations in circulating glucose levels and secrete insulin accordingly. We propose that in susceptible individuals, a gradual rise in blood glucose (hyperglycaemia) and lipid levels resulting from increasing obesity and insulin resistance leads to a loss of the unique expression pattern of genes necessary for appropriate insulin secretion. This exacerbates hyperglycaemia, which causes further beta-cell dedifferentiation and eventually the death of beta-cells by apoptosis. We have recently found evidence in several models of diabetes that supports this hypothesis. We propose to use animal studies and cell culture systems to investigate the following hypotheses important for our understanding of beta-cell failure and progression to diabetes: 1) The loss of beta-cell phenotype (dedifferentiation) underlies the loss of insulin secretory function in failing beta-cells. 2) Hyperglycaemia plays a critical role regulating the progression to beta-cell dedifferentiation. 3) The overexpression of key candidate gene products play an integral role linking hyperglycaemia to the loss of beta-cell secretion. 4) Endoplasmic reticulum stress is necessary for beta-cell death in diabetes. Our studies will make a major contribution to our understanding of why beta-cells fail in diabetes and aim to provide novel therapeutic targets in the treatment of diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New molecular mechanisms of islet protection against diabetes
  • 批准号:
    nhmrc : 1144206
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.52万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
New molecular mechanisms of islet protection against diabetes
  • 批准号:
    nhmrc : GNT1144206
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.33万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
Control of insulin secretion by Y1 receptor signalling
  • 批准号:
    nhmrc : 1144286
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
Control of insulin secretion by Y1 receptor signalling
  • 批准号:
    nhmrc : GNT1144286
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.56万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
国内基金
海外基金
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    孙贤杰
  • 依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
  • 批准号:
    82303919
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    陈鹭跃
  • 依托单位: